2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit 2018

The 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit 2018 covers topics such as:

• Commercialization and investment perspectives of Microbiome – based diagnostics and therapeutics
• Emerging science and technologies for successful Microbiome discovery and translation
• Regulatory compliance for Microbiome drugs
• Clinical applications of Microbiome in oncology & beyond
• Translation of Microbiome products:

The 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit 2018 brings together senior attendees with responsibilities in:

• Microbiology
• Microbiome/Microbiota
• Autoimmune Disease
• Computational biology
• Inflammation
• Infectious Diseases
• Genotyping
• Food/Nutrition Science
• Data Management
• Biomarkers
• High-Throughput Screening
• Metagenomics
• Licensing or Technology Transfer
• Diagnostic & Clinical Applications
• Clinical trials
• Regulatory
• Molecular Biology
• Bacteria / Fungi / Viruses
• Immuno-oncology
• Molecular Diagnostics
• Vaccines
• Metabolic Disease
• Genomics
• Neurodegeneration / Gut-Brain Axis
• Epigenetics
• Bioinformatics
• Personalized / Targeted Therapeutics
• NGS
• Business Development/In-Licensing
• Venture Capitalists
• Market Access